Sole M&A adviser Surgvision

Kempen is proud to announce it has advised SurgVision on its sale to Bracco

Transaction highlights

Bracco has entered into an agreement with the shareholders of SurgVision to acquire 100% of the shares in SurgVision for an undisclosed consideration
This transaction highlights the sector expertise of Kempen’s Life Sciences and Healthcare team and its key role as financial advisor in cross-border M&A transactions in the sector

SurgVision

Founded in 2013 as a spin-off of the Technical University of Munich and funded by BioGeneration and DFZ Participaties
Specialised in developing fluorescence image guided surgery platform solutions using high-definition cameras and tracers
Its innovative products have the potential to address the current impact of positive resection margins in breast conserving surgery

Bracco

Bracco is one of the world’s leading companies in diagnostic imaging, with over 3,400 employees and EUR 1.3bn in annual revenues
The company has a portfolio of products, injectors and solutions for diagnostic applications such as X-ray imaging (including CT-scanning), MRI, contrast enhanced ultrasound, and nuclear medicine
Bracco is privately held and based in Italy, operating in over 90 countries worldwide
 

Contact

Jan De Kerpel

Transactions